A detailed history of Gendell Jeffrey L transactions in Beyond Air, Inc. stock. As of the latest transaction made, Gendell Jeffrey L holds 1,461,071 shares of XAIR stock, worth $788,978. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,461,071
Previous 1,120,297 30.42%
Holding current value
$788,978
Previous $2.2 Million 15.81%
% of portfolio
0.1%
Previous 0.12%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.3 - $2.15 $443,006 - $732,664
340,774 Added 30.42%
1,461,071 $2.54 Million
Q4 2023

Feb 14, 2024

BUY
$1.4 - $2.46 $42,000 - $73,800
30,000 Added 2.75%
1,120,297 $2.2 Million
Q3 2023

Nov 13, 2023

BUY
$2.31 - $4.18 $524,275 - $948,688
226,959 Added 26.29%
1,090,297 $2.52 Million
Q2 2023

Aug 11, 2023

BUY
$4.26 - $6.92 $508,367 - $825,798
119,335 Added 16.04%
863,338 $3.68 Million
Q1 2023

May 12, 2023

BUY
$5.65 - $7.56 $223,875 - $299,557
39,624 Added 5.63%
744,003 $5.02 Million
Q3 2022

Nov 10, 2022

BUY
$7.42 - $11.39 $393,497 - $604,034
53,032 Added 8.14%
704,379 $5.24 Million
Q2 2022

Aug 12, 2022

SELL
$4.96 - $7.83 $21,075 - $33,269
-4,249 Reduced 0.65%
651,347 $4.36 Million
Q1 2022

May 13, 2022

BUY
$6.33 - $9.53 $1.1 Million - $1.66 Million
173,709 Added 36.05%
655,596 $4.38 Million
Q4 2021

Feb 11, 2022

BUY
$8.44 - $15.61 $2.37 Million - $4.38 Million
280,835 Added 139.68%
481,887 $4.55 Million
Q3 2021

Nov 12, 2021

BUY
$5.9 - $12.54 $1.19 Million - $2.52 Million
201,052 New
201,052 $2.24 Million

Others Institutions Holding XAIR

About Beyond Air, Inc.


  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $16.1M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Gendell Jeffrey L Portfolio

Follow Gendell Jeffrey L and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gendell Jeffrey L, based on Form 13F filings with the SEC.

News

Stay updated on Gendell Jeffrey L with notifications on news.